Repurposing of Raltitrexed as an Effective G9a/EHMT2 Inhibitor and Promising Anti-Alzheimer's Agent.

Jana, Abhisek; Bellver-Sanchis, Aina; Griñán-Ferré, Christian; Banerjee, Deb Ranjan

Jana, Abhisek; Bellver-Sanchis, Aina; Griñán-Ferré, Christian; Banerjee, Deb Ranjan.

Afiliação

Jana A; Department of Chemistry, National Institute of Technology Durgapur, M G Avenue, Durgapur-713209 , West Bengal, India.
Bellver-Sanchis A; Pharmacology Section, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Neuroscience, Universitat de Barcelona (NeuroUB), Av. Joan XXIII 27-31, 08028 Barcelona, Spain.
Griñán-Ferré C; Pharmacology Section, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Neuroscience, Universitat de Barcelona (NeuroUB), Av. Joan XXIII 27-31, 08028 Barcelona, Spain.
Banerjee DR; Centro de Investigación en Red, Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.

ACS Med Chem Lett ; 14(11): 1531-1536, 2023 Nov 09.

Article em En | MEDLINE | ID: mdl-37974951

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2023 Tipo de documento: Article